InnovAge Holding Corp. (NASDAQ:INNV - Free Report) - Analysts at KeyCorp increased their Q4 2026 earnings estimates for InnovAge in a report issued on Thursday, August 20th. KeyCorp analyst M. Gillmor now expects that the company will post earnings of $0.09 per share for the quarter, up from their previous forecast of $0.07. KeyCorp has a "Overweight" rating and a $13.00 price target on the stock. The consensus estimate for InnovAge's current full-year earnings is $0.07 per share. KeyCorp also issued estimates for InnovAge's Q1 2027 earnings at $0.11 EPS, Q2 2027 earnings at $0.11 EPS, Q3 2027 earnings at $0.15 EPS, Q4 2027 earnings at $0.09 EPS and FY2027 earnings at $0.47 EPS.
Several other equities research analysts have also recently commented on the company. Wall Street Zen cut InnovAge from a "buy" rating to a "hold" rating in a research note on Sunday, May 17th. Weiss Ratings restated a "sell (d-)" rating on shares of InnovAge in a report on Thursday, August 13th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, InnovAge has an average rating of "Reduce" and an average target price of $10.00.
View Our Latest Stock Analysis on InnovAge
InnovAge Stock Performance
Shares of InnovAge stock opened at $10.96 on Monday. The company has a market cap of $1.49 billion, a P/E ratio of -121.78 and a beta of 0.39. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.26. The business has a 50-day moving average price of $10.96 and a two-hundred day moving average price of $9.08. InnovAge has a 1-year low of $3.51 and a 1-year high of $12.64.
Hedge Funds Weigh In On InnovAge
Several large investors have recently modified their holdings of the business. Legal & General Group Plc bought a new stake in shares of InnovAge in the second quarter valued at approximately $25,000. Invesco Ltd. bought a new position in InnovAge in the 4th quarter worth approximately $57,000. CIBC Asset Management Inc purchased a new position in InnovAge in the 4th quarter valued at approximately $57,000. Deutsche Bank AG raised its holdings in InnovAge by 15.1% during the 4th quarter. Deutsche Bank AG now owns 12,775 shares of the company's stock valued at $66,000 after acquiring an additional 1,679 shares during the period. Finally, Baron Wealth Management LLC bought a new stake in InnovAge during the 1st quarter valued at $104,000. Hedge funds and other institutional investors own 12.26% of the company's stock.
InnovAge Company Profile
(
Get Free Report)
InnovAge Holdings, Inc NASDAQ: INNV is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants' homes and community-based centers. InnovAge's approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.
The company's core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
